Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Cardiff Oncology Inc
About CRDF
Cardiff Oncology, Inc. is a clinical-stage biotechnology company advancing cancer treatments focused on Polo-like Kinase 1 (PLK1) inhibition, a validated oncology target with practice-changing potential. The Company's lead asset, onvansertib, is a highly specific, oral PLK1 inhibitor being evaluated in a Phase II trial for first-line treatment of RAS-mutated metastatic colorectal cancer (mCRC), addressing a large, underserved patient population with high unmet need. Onvansertib is also being evaluated in multiple other cancers through investigator-initiated studies, including metastatic pancreatic ductal adenocarcinoma (mPDAC), small cell lung cancer (SCLC), triple-negative breast cancer (TNBC), and chronic myelomonocytic leukemia (CMML). The Company's clinical development programs incorporate tumor genomics and biomarker assays to refine patient selection and assessment of patient response to treatment.
Find out what a historical investment in Cardiff Oncology Inc would be worth today using our CRDF stock calculator.
Market Capitalisation
$120.33M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
1.77M
High today
$1.88
Low today
$1.71
Open price
$1.72
52-week high
$4.56
52-week low
$1.48
Ready to start your investing journey with Stake?
Open an accountHow do I buy CRDF shares in Australia?
Buying CRDF shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Cardiff Oncology Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in CRDF
What is the ticker symbol of Cardiff Oncology Inc?
The ticker symbol for Cardiff Oncology Inc is CRDF.
How much is one share of CRDF?
One share of CRDF is valued at $1.84 as of 20 May 2026.
What is the market capitalisation of Cardiff Oncology Inc CRDF?
As of 20 May 2026 Cardiff Oncology Inc has a market cap of $120.33M.
What is the 52-week high for Cardiff Oncology Inc stock?
The Cardiff Oncology Inc 52-week high stock price is $4.56.
What is the 52-week low for Cardiff Oncology Inc stock?
The Cardiff Oncology Inc 52-week low stock price is $1.48.
Can I buy CRDF shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy CRDF shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in CRDF on Stake
- Buy CRDF from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of CRDF from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
CRDF related stocks